Agile Therapeutics, Inc. (AGRX) Social Stream



Agile Therapeutics, Inc. (AGRX): $1.22

0.01 (+0.83%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Featured Post From StockTwits About AGRX

$AGRX remember, i'm rooting for you.. the most basic question that should matter with any investment... Is the growth rate of how many people that will want to use this product in comparison to others in the future positive or negative. In an innovative world with contraceptive options that don't release any hormones, will this 2.8% patch makeup of CHC market share go up or down. Wearing a patch on your body, a decent sized one, showering with it, working out with it, and changing it 3 times a month. There will always be those who don't want invasive products, can't swallow pills, etc.. so there probably is a buying time for AGRX when it gets beat up enough.. Xulane is likely to get delisted if Twirla doesn't fuck up. It's proving grounds time right now, and there's a lot of work left for Al and Agile... waiting for extra blood
lezch1ll, published July 24, 2021

Other Notable StockTweets About AGRX


$AGRX look at the chart... proof that funds are saying no thanks this is a terrible investment, we'll certainly make money shorting it. for a year and a half people have been saying... "Loading up more, what a discount at this price"... "A buyout is coming!!!" "Xulane did 300M that means Twirla will"... from $4 downt to $1. think about how much time was wasted and how much mario pumped the company. A contraceptive company run by a dude who sounds terrible in any setting where hes publicly speaking, not a female on camera who is speaking about this... its all in the chart. this company was overhyped to begin with. Go over to BXRX.. the other board that Al serves on. They shat the bed too with their launch of ANJESO. Theyre about to reverse split!! Last time Al will be a CEO. Remember a couple earnings ago when Al was shitting himself using terms like "knock on wood" being hopeful about the product launch? Call me a hater i just think its so funny if youre still long this company

lezch1ll, published July 20, 2021

$AGRX what are some of your top questions you’d like answered at this upcoming conference call?

Here’s my list:

If our three sales options are: 1) New starts (we know patches account for roughly 1% of all birth control methods so this seems like a huge waste of time and ad money)
2) Convince someone to change methods of birth control. (Good luck with that.)
3) Switch someone who is already using a patch from Xulane to Twirla (Ding, ding, ding, ding!!)

Why on earth have we not done a full on marketing ad campaign directly target at current Xulane users?

Next question: What in the world on the crappy formulary and managed care coverage? Are we just permanently blocked? Need more time? How much time? When do they anticipate progress? That in and of itself could 2x our existing script numbers if we could add the other 2/3 of major formularies…

Final Question: “Al, at what age do you plan to retire?”

Carebear out-

Carebearstare, published July 15, 2021

$AGRX - in support of @SlappyStocks777 post regarding us already being bought - Al & Dennis have a history of selling companies, execs updated their golden parachutes in Aug, execs are loaded in shares and options, connections and proximity to other big pharma

we may be intentionally stalled on stage 6. management may delay accepting an offer as dilution allows insiders including Perceptive a bigger piece of the pie. stalling also makes sense if there are multiple bidders.

until then we have to proceed with the bumpy road of a do it alone scenario. maybe have a asset sell - license out skin fusion which would lessen the profitability timeline gap

keep the faith, have a logical mind and think like a tute which you know they are buying up the ATM shares...

https://corporatefinanceinstitute.com/resources/knowledge/deals/mergers-acquisitions-ma-process/

Super_Marioo, published July 3, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5924 seconds.